Stability indicating method development and validation of nitisinone in pure form in marketed pharmaceutical dosage form by using RP-HPLC
Abstract
A simple and rapid reverse phase-high performance liquid chromatography (RP-HPLC) method was developed and validated for quantitative determination of Nitisinone in bulk drug and marketed formulations. Nitisinone was analyzed by using reverse phase Develosil ODS HG-5 RP C18, 5µm, 15cmx4.6mm i.d., with mobile phase consisting of Methanol and Phosphate buffer (0.02M, pH-3.6) in the ratio of 45:55%v/v. The flow rate was set 1.0 ml/min and the analysis was performed at wavelength 255 nm using Ultra Violet (UV) detector at ambient temperature. The method was validated according to Guidelines of ICH. The retention time for Nitisinone was around 3.254 minutes. The calibration curves were linear (r 2- 0.9995) over a concentration range from 12.0 to 28.0µg/ml. Limit of detection (LOD) and Limit of quantitation (LOQ) were found to be 5.004µg/ml and 15.164µg/ml respectively. The developed method was successfully applied to estimate the amount of Nitisinone in bulk form and Marketed Pharmaceutical Dosage form.
How to Cite This Article
Dr. Husna Kanwal Qureshi, Naaz Fatima, Sumaiya Fatima, Syeda Salwa Fatima Banu, Mohammed Nadeem Uddin, Syeda Hafsa Noorain (2024). Stability indicating method development and validation of nitisinone in pure form in marketed pharmaceutical dosage form by using RP-HPLC . International Journal of Multidisciplinary Research and Growth Evaluation (IJMRGE), 5(4), 199-205. DOI: https://doi.org/10.54660/.IJMRGE.2024.5.4.199-205